肺癌生物靶向治疗得效与中医瞑眩反应
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(81774166);上海市卫计委市级医疗卫生优秀学术带头人培养计划资助项目(2017BR044);上海市申康医院发展中心市级医院新兴前沿前沿技术联合攻关项目(SHDC12016114)


Effects of Biological Targeted Therapy in Lung Cancer and Dizziness Response in Traditional Chinese Medicine
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    肺癌生物靶向治疗主要有酪氨酸激酶抑制剂、血管生长因子受体抑制剂、免疫检查点阻滞剂、免疫细胞治疗等,这些治疗方法的作用机制各有差异,临床上常见药后不良反应主要为皮疹、腹泻等。结合不良反应与疗效的关系以及中医“瞑眩反应”理论,将治疗伴随的皮疹和腹泻建议定为“药疹”和“药泄”,充分利用“瞑眩反应”理论在中西医融合治疗肺癌中的指导价值,辨证地认识与处理生物靶向治疗的不良反应,以丰富“瞑眩反应”的内涵。

    Abstract:

    Biological targeted therapies for lung cancer mainly include tyrosine kinase inhibitors,vascular growth factor receptor inhibitors,immune checkpoint inhibitors and immunological cytotherapy.Although the mechanisms of these therapies are different,side effects in clinic are mainly skin rash and diarrhea.Based on the relationship between these reactions and their corresponding curative effects as well as the theory of “dizziness response” in traditional Chinese medicine(TCM),we suggest that the skin rash and diarrhea should be defined as “drug eruption” and “drug diarrhea”.We should make full use of the guidance value in the theory of “dizziness response” in the treatment of lung cancer using integrated traditional Chinese and western medicine,to dialectically understand and cope with the adverse reactions in biological targeted therapies,so as to enrich the connotation of “dizziness response”.

    参考文献
    相似文献
    引证文献
引用本文

罗斌,刘海涛,李和根,田建辉.肺癌生物靶向治疗得效与中医瞑眩反应[J].世界中医药,2019,(09).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2018-08-27
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-10-28
  • 出版日期:
文章二维码